These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20441504)

  • 1. Interpretation and utility of drug of abuse immunoassays: lessons from laboratory drug testing surveys.
    Melanson SE; Baskin L; Magnani B; Kwong TC; Dizon A; Wu AH
    Arch Pathol Lab Med; 2010 May; 134(5):735-9. PubMed ID: 20441504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation and Utility of Drug of Abuse Screening Immunoassays: Insights From Laboratory Drug Testing Proficiency Surveys.
    Krasowski MD; McMillin GA; Melanson SEF; Dizon A; Magnani B; Snozek CLH
    Arch Pathol Lab Med; 2020 Feb; 144(2):177-184. PubMed ID: 31313960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory testing for drug abuse.
    Warner EA; Friedmann PD
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):854, author reply 854. PubMed ID: 16894087
    [No Abstract]   [Full Text] [Related]  

  • 6. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005.
    Ventura M; Pichini S; Pujadas M; Ventura R; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; Jurado C; de la Torre R
    Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
    Gingras M; Laberge MH; Lefebvre M
    J Anal Toxicol; 2010 Mar; 34(2):78-83. PubMed ID: 20223099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology.
    Leclercq M; Soichot M; Delhotal-Landes B; Bourgogne E; Gourlain H; Mégarbane B; Labat L
    J Anal Toxicol; 2020 Mar; 44(2):200-205. PubMed ID: 31384953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.
    Haller CA; Stone J; Burke V; Branch J; Chen K; Gross S
    J Anal Toxicol; 2006 Mar; 30(2):106-11. PubMed ID: 16620541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of immunoassays for urine drug testing.
    Melanson SE
    Clin Lab Med; 2012 Sep; 32(3):429-47. PubMed ID: 22939301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays.
    Melanson SE; Lee-Lewandrowski E; Griggs DA; Long WH; Flood JG
    Arch Pathol Lab Med; 2006 Dec; 130(12):1834-8. PubMed ID: 17149959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
    Fraser AD; Howell P
    J Anal Toxicol; 1998; 22(1):50-4. PubMed ID: 9491969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive interferences of common urine drug screen immunoassays: a review.
    Saitman A; Park HD; Fitzgerald RL
    J Anal Toxicol; 2014 Sep; 38(7):387-96. PubMed ID: 24986836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
    Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
    J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory monitoring of OxyContin (oxycodone): clinical pitfalls.
    Von Seggern RL; Fitzgerald CP; Adelman LC; Adelman JU
    Headache; 2004 Jan; 44(1):44-7. PubMed ID: 14979882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine.
    Gomila I; Moranta C; Quesada L; Pastor Y; Dastis M; Torrents A; Elorza MÁ; Busardò FP; Barceló B
    Bioanalysis; 2017 Nov; 9(22):1771-1785. PubMed ID: 28975809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples. Steering Committee for the United Kingdom National External Quality Assessment Scheme for Drugs of Abuse in Urine.
    Wilson JF; Smith BL
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():592-600. PubMed ID: 10505208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recreational drug use at a major music festival: trend analysis of anonymised pooled urine.
    Hoegberg LCG; Christiansen C; Soe J; Telving R; Andreasen MF; Staerk D; Christrup LL; Kongstad KT
    Clin Toxicol (Phila); 2018 Apr; 56(4):245-255. PubMed ID: 28814125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.